Dr Shrikala Baliga

Professor and Associate Dean

Department of Microbiology


    • Dr Shrikala Baliga is Associate Dean, Academics and International Collaboration and Professor in the Department of Microbiology
    •  Roles
      1. Director, Kasturba Medical College Laboratory Services
      2. Teaching UGs and Training Postgraduate students (MD and PhD) 
      3. Guide for UG/ MD/ PhD students           


Subject Semester / Year


Degree Specialisation Institute Year of passing
MD Microbiology Kasturba Medical College, Mangalore, Mangalore University 1994
MBBS( Bachelor of Medicine , Bachelor of Surgery) Grant Medical College, Mumbai University 1989


Institution / Organisation Designation Role Tenure
Kasturba Medical College, Mangalore Associate Dean 01/01/2022 - till date
Department of Microbiology, KMC Mangalore Professor 2010 - Till date
Department of Microbiology, KMC Mangalore Professor and Head of the Department 2010 to 30/09/2015
Department of Microbiology, KMC Mangalore Additional Professor 2009-2010
Department of Microbiology, KMC Mangalore Associate Professor 2000-2009
Department of Microbiology, KMC Mangalore Assistant Professor 1995-2000
Department of Microbiology, KMC Mangalore Tutor 1991-1994

1. ASPIRE STUDY (A Surveillance study on The Antibiotic Susceptibility Pattern of Bacterial Isolates collected from Patients at various Indian Tertiary Care Hospitals – A Multicentric PAN India study) PI: Dr. Shrikala Baliga  CoI: Dr. Suchitra Shenoy Wockhardt Limited WOC/AMS/CT-44/14. Rs. 4,39,346 (2016)

2. Evaluation of Fluorescent In Situ Hybridization (FISH) as a Diagnostic Tool for Rapid Detection of Pulmonary and extra Pulmonary Tuberculosis with special emphasis on speciation of culture positive Mycobacterial Species. Funded by ID FISH Technology Inc.,IEC KMC MLR 12-15/286. Rs. 16,48,800 (2015) Ph.D Student: Ms. Leesha Sharon

3. Attitude and Knowledge of Antibiotic usage among people of Dakshina Kannada District and estimation of burden of antibiotic resistant gut bacteria in humans and poultry – A community based study. DBT Scholarship DBT/JRF/BET-16/I/2016/AL/08-438 Rs. 11,88,000    Ph.D Student: Ms. Khyati Bhardwaj. Guide: Dr. Shrikala Baliga Co-Guide: Dr. Suchitra Shenoy

4. Susceptibility testing of WCK 771 discs with recent 250 clinical isolates in tertiary care hospital. PI: Dr. Shrikala Baliga ,Co PI Dr. Suchitra Shenoy. Wockhardt Limited. Rs 40,000

5. Antimicrobial and Antibiofilm property of Melanin Pigment from Pseudomonas stutzeri: A Novel Agent  PI: Dr. Suchitra Shenoy M Co-Investigators: Dr. Shrikala Baliga Dr. KeyurRaval, (NITK, Surathkal) . MAHE Seed Money grant. Rs. 25,000  - Feb 2019 

6.  Baliga, B.S., Baliga, S., Jain, A. et al. Digitized smart surveillance and micromanagement using information technology for malaria elimination in Mangaluru, India: an analysis of five-year post-digitization data. Malar J 20, 139 (2021). 

7.    Knowledge, attitude, and practices related to antibiotic use and resistance among the general public of coastal south Karnataka, India – A cross-sectional survey. Khyati Bhardwaj, Suchitra Shenoy M, Shrikala Baliga, B. Unnikrishnan, B. Shantharam Baliga, Clinical Epidemiology and Global Health, 2021, Vol11,100717,

8  Characterization of antibiotic resistant phenotypes and linked genes of Escherichia coli and Klebsiellapneumoniae from healthy broiler chickens, Karnataka, India, Khyati Bhardwaj, Suchitra Shenoy M, Shrikala Baliga, Unnikrishnan B, B. Shantharam Baliga, Vasanth Kumar Shetty, Poultry Science, 2021, Vol 100, Issue 6, 101094

9.  Candida profile in HIV-Positive children needs a Dynamic clinical appraisal: A Microbiological Study

Research J. Pharm. and Tech. 16(1): January 2023.

10  India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-care. Indian J Med Microbiol. 2023 Jan-Feb;41:71-80. doi: 10.1016/j.ijmmb.2022.11.005. Epub 2022 Dec 9. PMID: 36509611

11. Evaluation of role of Tigecycline among clinically significant multidrug resistant pathogens from a tertiary care hospital F1000 research: June 2024,13:36


Area of Interest

Diagnostic Microbiology, Hospital Infections, Quality Assurance, Drug Resistance

Area of Expertise

Quality Assurance as per National Accreditation Board for Laborataries (Lead Assessor and Technical Assesor), Hospital infection control

Area of Research

Drug Resistance, Infectious Diseases, Hospital infection control,Mycobacteriology, One Health

Professional Affiliations & Contributions

i. Director KMC Diagnostic Centre, 2003-2011
ii. Life member of Indian Association of Medical Microbiology.
iii. Member of International Union against TB
iv. Life Member Association of Clinical Microbiologists
v. Empanelled Lead and Technical Assessor for NABL
vi. Member of Academic Council of BLDE Deemed to be University, Bijapur, Karnataka
vii. Member, Core Committee for National AIDS Control Organisation (NACO) for strengthening of HIV Testing Laboratories. 2008-2012
viii. Appointed as core committee member for NACO for writing Manual on National Guidelines for Quality Control in HIV Testing-2008-2012
ix. Technical Working Group, National task force for Laboratory Policy and Strategic Action Plan for comprehensive laboratory strengthening, Ministry of Health and Family Welfare, 2017
x. Member, Task Force for National Viral Hepatitis Control Programe, Ministry of Health and Family Welfare, 2017-2018
xi. Expert Committee member for RGUHS for drafting curriculum for CBME-2020


1.Performance of Cepheid Xpert HIV-1 viral load plasma assay to accurately detect treatment failure. Sacks, Jilian A.a; Fong, Youyib; Gonzalez, Mercedes Perezc; Andreotti, Maurod; Baliga, Shrikalae; Garrett, Nigelf; Jordan, Jeanneg; Karita, Etienneh; Kulkarni, Smitai; Mor, Ornaj; Mosha, Faustak; Ndlovu, Zibusisol; Plantier, Jean-Christophem; Saravanan, Shanmugamn; Scott, Lesleyo; Peter, Trevora; Doherty, Megc; Vojnov, Larac AIDS: October 1, 2019 - Volume 33 - Issue 12 - p 1881–1889
2.In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016–18. Boppe Appalaraju, Sujata Baveja, Shrikala Baliga, Suchitra Shenoy, Renu Bhardwaj, Vaishali Kongre,, Gogi Suresh Dattatraya5, Tapan Dhole6, Binita Verma, D. N. Mukherjee, Shalini Gupta, Priyadarshini Shanmugam, Jyoti Iravane, Sudhi Ranjan Mishra, Purabi Barman, Shimpi Chopra1Meenakshi Hariharan, Rajendra Surpam, Rana Pratap16, Prashant Joshi, Hemant Khande, Ashish Mane, Rishi Jain and Sachin Bhagwat. JAC , 2019 Dec 16. pii: dkz493. doi: 10.1093/jac/dkz493. [Epub ahead of print]
3.Use of GeneXpert TB System for Viral Load Testing in India. Malden Nash, Shrikala Baliga John Ramapuram, Ramya Nidhi Kaiya, Sophie Huddart, Madhukar Pai. Lancet Global Health, Vol 5, August 2017. 754-755
4.Performance of the Xpert HIV-1 Viral Load Assay: A Systematic Review and Meta-analysis Madlen Nash, Sophie Huddart, Sayema Badar, Shrikala Baliga, Kavitha Saravu, Madhukar Pai. JCM.April 2018 Volume 56 Issue 4 e01673-17
5.Rapid method for detecting and differentiating Mycobacterium tuberculosis complex and non-tuberculous mycobacteria in sputum by fluorescence in situ hybridization with DNA probes. Shrikala Baliga, Christina Murphy, Leesha Sharon, Suchitra Shenoy, Dhanashree Biranthabail, Helena Weltman, Steve Miller, Ranjan Ramasamy, Jyotsna Shah, International J Infectious Disease 2018 75;1-7
6.Dual Colour Florescence In situ Hybridization(FISH) assays for detectiong Mycobacterium tuberculosis and Mycobacterium avium complexes and related pathogens in culture. Jyotsna Shah, Helena Weltman, Patricia Narciso, Christina Murphy, Akhila Poruri, Shrikala Baliga, Leesha Sharon, Mary York, Gail Cunningham, Steve Miller, Luz Caviedes, Robert Gilman, Edward Desmond, Ranjan Ramasamy. Plos One 12(4): e0174989.